Skip to main content

Lateral Epicondylitis

0
Pipeline Programs
3
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Radiance Biopharma
1 program
Active PBMT-sMFN/A1 trial
Active Trials
NCT04829734Completed50Est. Sep 2021
Zimmer Biomet
Zimmer BiometFL - Jacksonville
1 program
Leukocyte- and Platelet-Rich PlasmaN/A1 trial
Active Trials
NCT02588040Terminated18Est. Sep 2017
City Therapeutics
City TherapeuticsMA - Cambridge
1 program
Platelet Rich PlasmaN/A1 trial
Active Trials
NCT01851044CompletedEst. Dec 2017

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Radiance BiopharmaActive PBMT-sMF
Zimmer BiometLeukocyte- and Platelet-Rich Plasma
City TherapeuticsPlatelet Rich Plasma

Clinical Trials (3)

Total enrollment: 68 patients across 3 trials

Effects of Photobiomodulation Therapy Combined With Static Magnetic Field in Patients With Lateral Epicondylitis

Start: Apr 2021Est. completion: Sep 202150 patients
N/ACompleted
NCT02588040Zimmer BiometLeukocyte- and Platelet-Rich Plasma

Recover L-PRP in Lateral Epicondylitis (REGP-11-00)

Start: May 2016Est. completion: Sep 201718 patients
N/ATerminated
NCT01851044City TherapeuticsPlatelet Rich Plasma

The Effect of Platelet Rich Plasma on Lateral Epicondylitis

Start: Feb 2011Est. completion: Dec 2017
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.